quinuclidines has been researched along with Colonic Diseases, Functional in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Copé, R | 1 |
| Lydiard, RB | 1 |
| Baird, AW; Goldhill, J; Moriarty, D; Selve, N | 1 |
| Alexopoulou, A; Dourakis, SP; Michael, A | 1 |
| Ikeda, K; Kobayashi, S; Miyata, K; Suzuki, M; Yamada, T | 1 |
| Cohen, S; Snape, WJ; Sullivan, MA | 1 |
| Gupta, JP; Jain, AK; Tripathi, SN; Yadav, SK | 1 |
1 review(s) available for quinuclidines and Colonic Diseases, Functional
| Article | Year |
|---|---|
Anxiety and the irritable bowel syndrome: psychiatric, medical, or both?
Topics: Aged; Agoraphobia; Anxiety Disorders; Catchment Area, Health; Chlordiazepoxide; Colonic Diseases, Functional; Comorbidity; Drug Combinations; Female; Health Surveys; Humans; Male; Mental Disorders; Models, Neurological; National Institute of Mental Health (U.S.); Panic Disorder; Prevalence; Quinuclidines; United States | 1997 |
3 trial(s) available for quinuclidines and Colonic Diseases, Functional
| Article | Year |
|---|---|
[Comparative clinical study of the combination of clidinium(br)-chlordiazepoxide and trimebutine in the treatment of functional colopathies].
Topics: Adult; Benzoates; Chlordiazepoxide; Colonic Diseases, Functional; Double-Blind Method; Drug Combinations; Drug Tolerance; Female; Humans; Male; Middle Aged; Quinuclidines; Trimebutine | 1981 |
Colonic myoelectrical activity in irritable-bowel syndrome. Effect of eating and anticholinergics.
Topics: Administration, Oral; Adult; Aged; Clinical Trials as Topic; Colon; Colonic Diseases, Functional; Eating; Electrophysiology; Gastrointestinal Motility; Humans; Middle Aged; Muscle Contraction; Parasympatholytics; Quinuclidines | 1978 |
Irritable bowel syndrome: therapeutic evaluation of indigenous drugs.
Topics: Adolescent; Adult; Chlordiazepoxide; Colonic Diseases, Functional; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Medicine, Ayurvedic; Middle Aged; Plants, Medicinal; Quinuclidines; Quinuclidinyl Benzilate; Randomized Controlled Trials as Topic | 1989 |
3 other study(ies) available for quinuclidines and Colonic Diseases, Functional
| Article | Year |
|---|---|
Potent NK1 antagonism by SR-140333 reduces rat colonic secretory response to immunocyte activation.
Topics: Animals; Benzamides; Capsaicin; Colon; Colonic Diseases, Functional; Electric Stimulation; Male; Mast Cells; Neurokinin A; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Piperidines; Quinuclidines; Rats; Rats, Inbred Strains; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3; Stress, Physiological; Substance P | 2001 |
Acute thrombocytopenic purpura in a patient treated with chlordiazepoxide and clidinium.
Topics: Acute Disease; Aged; Chlordiazepoxide; Colonic Diseases, Functional; Drug Combinations; Humans; Male; Purpura, Thrombocytopenic; Quinuclidines | 2001 |
Effects of YM905, a novel muscarinic M3-receptor antagonist, on experimental models of bowel dysfunction in vivo.
Topics: Animals; Bethanechol; Cholera Toxin; Colonic Diseases, Functional; Defecation; Diarrhea; Dinoprostone; Disease Models, Animal; Intestines; Isoquinolines; Male; Muscarinic Antagonists; Neostigmine; Nicotine; Quinuclidines; Rats; Receptor, Muscarinic M3; Receptors, Muscarinic; Serotonin; Solifenacin Succinate; Stress, Physiological; Tetrahydroisoquinolines | 2001 |